199 Biotechnologies is an early-stage
company developing first-in-class therapies that target the fundamental mechanisms of aging, with the goal of transforming the landscape of age-related disease treatment and prevention.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 199 Gloucester Terrace, London,england W2 6ld,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://199.bio/
- Keywords
- London.
- HQ
- London, England
199 Biotechnologies Questions
199 Biotechnologies's website is https://199.bio/
199 Biotechnologies's LinkedIn profile is https://uk.linkedin.com/company/199-bio
199 Biotechnologies has
5 employees.
View email and phone details for 5
employees at 199 Biotechnologies.
199 Biotechnologies's industry is
Biotechnology Research
199 Biotechnologies's top competitors are
Aavantgarde,
London Longevity Clinic,
Neobe Therapeutics,
Nanologistics,
Relation,
Asy Health Clinic,
Labgenius Therapeutics,
Vivoarchitect,
Cell And Gene Therapy Catapult,
Loqus23 Therapeutics Ltd.
199 Biotechnologies's categories are Biotechnology Research
199 Biotechnologies's founding year is 2023
